Which medication is a selective alpha-1 blocker commonly used to improve urine flow in BPH?

• A. Tamsulosin
• B. Finasteride
• C. Oxybutynin
• D. Bethanechol

Answer: (A)

The main concept is that relieving bladder outlet resistance in BPH is achieved with drugs that relax smooth muscle in the prostate and bladder neck. A selective alpha-1 blocker does just that by blocking alpha-1 receptors concentrated in these tissues, which lowers outlet resistance and improves urine flow.

Tamsulosin is the classic example because it is selective for the alpha-1A subtype found mainly in the prostate and bladder neck. By targeting this receptor, it relaxes the smooth muscle in the prostatic stroma and bladder neck, which reduces resistance to urine flow and typically improves symptoms and peak urinary flow with fewer blood pressure-related side effects.

Finasteride works differently; it’s a 5-alpha-reductase inhibitor that gradually shrinks the prostate over months, so it’s not the go-to for immediate improvement in urine flow. Oxybutynin is an antimuscarinic that lowers bladder overactivity, which can help in overactive bladder but does not relieve obstruction and can worsen retention in BPH. Bethanechol is a cholinergic agonist that stimulates detrusor contractions, which can worsen obstruction in BPH rather than improve flow.

So the medication that best fits the goal of improving urine flow in BPH by selectively blocking alpha-1 receptors is the one that targets the prostate/bladder neck while minimizing systemic blood pressure effects.